Nexelis, a Canada-based provider of advanced assay development and laboratory testing services in infectious, oncologic, and metabolic diseases and an Ampersand Capital Partners portfolio company, has acquired AIT Bioscience, LLC, a U.S.-based integrated bioanalytical laboratory with liquid chromatography–mass spectrometry (LC-MS) and immunoassay testing capabilities.  The acquisition expands Nexelis’ geographic customer reach and supports its expertise in servicing the bioanalytical segment, …

Medtronic plc, a major, $28.9b medical device maker of cardiovascular, orthopedic, spinal and other surgical devices, is buying Medicrea, a France-based developer of patient-specific, 3D-printed titanium spinal implants and related workflow software that helps surgeons use predictive modeling to digitally reconstruct a patient’s spine profile. The deal complements Medtronic’s recent $1.6b acquisition of robotic spinal surgery guidance system developer Mazor …

UK-based producer of diagnostic reagents LGC has purchased The Native Antigen Company (NAC), a UK-based supplier of recombinant viral and bacterial antigens, antibodies and immunoassays. NAC was among the first companies to offer antigens for SARS-COV-2 on a global scale.  The deal adds >60 viral and infectious disease products to LGC’s existing portfolio of assurance tools, immunoassays and probes and primers for molecular diagnostics.  Terms not announced. …

Teladoc Health, Inc. (NYSE: TDOC), a $553.3m provider of virtual healthcare services purchased InTouch Health, a producer of telehealth software and devices including tablets, remote monitoring systems and portable carts that mount HDMI-enabled televisions or monitors for physicians to view patients during telehealth appointments.  The acquisition helps Teladoc scale and enable hospitals and physician practices to virtualize amid the seismic …

LeMaitre Vascular, a $117.2m maker of specialized catheters, shunts and grafts to treat peripheral vascular disease has acquired Artegraft, Inc., a developer of bovine carotid artery-derived biologic grafts used to treat hemodialysis access patients, for $72.5m upfront and milestones of up to $17.5m.  Artegraft’s sales grew 10% in 2019.  During the trailing 12 months ended 5/31/20, Artegraft generated trade sales …

iSchemaView Inc. d/b/a/ RapidAI, a developer of an advanced cerebrovascular imaging platform, purchased EndoVantage, producer of the “Find, Track and Treat” cerebral aneurysm management platform.  The deal provides RapidAI with the capability to automate the entire cerebral aneurysm and stroke workflow from initial assessment, to growth monitoring, to treatment planning.  EndoVantage’s platform, initially developed at the Mayo Clinic and Arizona State University, uses computed …

UK-based orthotics and prosthetics producer Steeper Group has acquired College Park Industries’ Espire elbow prostheses range.  The Espire range includes five mechanical elbow models with prosthetic elbow joint control enabling patients to perform everyday weight-bearing activities.  The acquisition builds on Steeper’s upper limb product portfolio and U.S. market penetration.  The deal followed Iceland-based Össur’s acquisition of College Park Industries, which …

Nordson Corporation, a $2.2b developer of dispensing and fluid management systems for adhesives, industrial coatings, sealants, paints, polymers, fluids and biomaterials, has acquired Fluortek Inc., a maker of precision plastic extrusion products.  Fluortek’s offerings include polytetrafluoroethylene, heatshrink, micro-bore, fluoropolymer, thermoplastic, radiopaque and splittable tubing, multi-lumen and profile extrusions, and etched liners for use in central venous, balloon and urinary catheters, …

Conventus Orthopaedics, developer of a self-expanding nitinol cage technology for repairing fractured wrists, elbows, and shoulders and portfolio company of healthcare investment firm Deerfield Management, has acquired Flower Orthopedics, a maker of disposable, sterile-packed, implant and instrument kits.  Flower complements Conventus’ orthopedic fracture fixation system with an alternative to reusable implant trays that carry greater bioburden risk and provides entry …

The Walden Group is pleased to provide access to an Interim Healthcare Industry Report providing a window into how the healthcare industry is taking steps to resume some semblance of normality. It discusses how medical practices and hospitals are carefully opening up, compliant with Covid-19 safety guidelines. It unpacks the effect of the pandemic on various clinical areas: General Surgery, …